FAT1 and head and neck squamous cell carcinoma: However, the FAT1‐HR subgroup showed significantly lower five‐year OS and RFS rates than the FAT1‐LR subgroup, in advanced‐stage HNSCC patients (p = 7e−06 and 0.002, respectively; Fig. 4B,D).